CUMBERLAND PHARMACEUTICALS INC Annual Return On Equity in % from 2012 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cumberland Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2024.
  • Cumberland Pharmaceuticals Inc Return On Equity for the quarter ending December 31, 2024 was -25.9 %, a 41.9% decline year-over-year.
  • Cumberland Pharmaceuticals Inc annual Return On Equity for 2024 was -25.9 %, a 41.9% decline from 2023.
  • Cumberland Pharmaceuticals Inc annual Return On Equity for 2023 was -18.2 %, a 26.7% decline from 2022.
  • Cumberland Pharmaceuticals Inc annual Return On Equity for 2022 was -14.4 %, a 88.6% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -25.9 -7.63 -41.9% Jan 1, 2024 Dec 31, 2024
2023 -18.2 -3.84 -26.7% Jan 1, 2023 Dec 31, 2023
2022 -14.4 -6.76 -88.6% Jan 1, 2022 Dec 31, 2022
2021 -7.63 -0.71 -10.3% Jan 1, 2021 Dec 31, 2021
2020 -6.92 -0.24 -3.59% Jan 1, 2020 Dec 31, 2020
2019 -6.69 +5.21 +43.8% Jan 1, 2019 Dec 31, 2019
2018 -11.9 +0.03 +0.25% Jan 1, 2018 Dec 31, 2018
2017 -11.9 -10.7 -839% Jan 1, 2017 Dec 31, 2017
2016 -1.27 -2.21 -236% Jan 1, 2016 Dec 31, 2016
2015 0.94 -2.08 -68.9% Jan 1, 2015 Dec 31, 2015
2014 3.02 +5.58 Jan 1, 2014 Dec 31, 2014
2013 -2.57 -9.56 -137% Jan 1, 2013 Dec 31, 2013
2012 7 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.